Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. [electronic resource]
- Journal of the American College of Cardiology Feb 2006
- 685-6 p. digital
Publication Type: Letter; Meta-Analysis
1558-3597
10.1016/j.jacc.2005.11.018 doi
Abciximab Angioplasty, Balloon, Coronary Antibodies, Monoclonal--therapeutic use Combined Modality Therapy Electrocardiography Humans Immunoglobulin Fab Fragments--therapeutic use Myocardial Infarction--mortality Platelet Aggregation Inhibitors--therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors Randomized Controlled Trials as Topic Risk Factors Survival Rate